Andrew Oxtoby - Chief Commercial Officer at Chinook Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Stock Symbol
KDNY
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew Oxtoby since 12/22/2023

Holdings reported by Andrew Oxtoby for Chinook Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 0 Aug 11, 2023 Direct Common Stock
Stock Option (Right to Buy) 0 $26.12 Aug 11, 2023 Direct Common Stock

Transactions reported by Andrew Oxtoby for Chinook Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.